A data-driven approach towards generation of permeable peptide therapeutics
A data-driven approach towards generation of permeable peptide therapeutics
批准号:
10241206
负责人:
Parisa Hosseinzadeh
金额:
$130.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-22 至 2024-08-31
关键词:
AddressAffinityAntibodiesArtificial MembranesCategoriesCell membraneCellsComputational TechniqueComputational algorithmComputing MethodologiesDataData SetDevelopmentDiseaseDrug TargetingDrug usageGenerationsLibrariesMachine LearningMammalian CellMethodsModalityModelingModificationPeptidesPermeabilityPharmaceutical PreparationsPhysicsResearch PersonnelSurfaceTestingTherapeuticTherapeutic UsesWorkbasedesigndrug discoveryfallsinterdisciplinary approachinterestnext generationnovelpeptide drugrapid techniquescreeningsmall moleculetherapeutic developmentuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
A staggering number of potential targets for combating diseases fall into a category called undruggable,
targets that are not accessible to two commonly used drug modalites: antibodies and small molecules. These
undruggable targets often reside inside the cells and cannot be accessed by antibodies, which are too large to
cross the cell membrane. Their flat surfaces deviate from the common deep pockets that are often hit by small
molecules. To untap the potential of these targets, we need a therapeutic modality that can target shallow
pockets and cross the cell membrane. Peptides are at the size range and composition that can be an ideal
choice as this alternative modality.
Despite efforts in developing high affinity peptide binders, generating permeable binders has been a
long-standing challenge. The few examples of cell permeable functional peptides are often developed through
error and trial or via many rounds of modification and testing. The challenge in obtaining permeable binders is
mainly due to lack of high throughput methods to screen for permeability, which has not only limited the power
of library-based screening for obtaining permeable binders, but has also resulted in a limited amount of
experimental data from which one can deduce rules that govern a peptide permeable. Thus, the use of
peptides as therapeutics to drug the undruggable has remained largely underdeveloped.
This proposal uses an interdisciplinary approach to address this challenge. We generate a network to
represent the peptide space in a meaningful manner. We then cluster this network and select for experimental
testing a set that is truly representative of the peptide space. The results of our tests, which include both
artificial membrane analysis and cellular uptake in bacterial and mammalian cells, can thus be generalized to
the entire space. This unprecedented dataset will then be used as a starting point to gain better understanding
of peptide permeability and to develop experimental and computational methods for rapid identification of
permeable peptide binders that can be used as leads for therapeutic development. We will use this dataset to
develop an automated generative algorithm that computationally designs permeable peptides that can target a
target interface of interest.
This proposal is a leap in the field of peptide therapeutic development. The dataset generated during this
work and methods we develop will be the stepping stone for many researchers interested in drug discovery,
physics-based models of permeability, and peptide therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancing genetic code expansion with Rosetta computational design: improving machinery for bioorthogonal amino acids
-
批准号:9189236
-
项目类别:
-
资助金额:$5.25万
-
财政年份:2016
-
负责人:Parisa Hosseinzadeh
-
依托单位:
Advancing genetic code expansion with Rosetta computational design: improving machinery for bioorthogonal amino acids
-
批准号:9390387
-
项目类别:
-
资助金额:$0.28万
-
财政年份:2016
-
负责人:Parisa Hosseinzadeh
-
依托单位:
Advancing genetic code expansion with Rosetta computational design: improving machinery for bioorthogonal amino acids
-
批准号:9337262
-
项目类别:
-
资助金额:$5.67万
-
财政年份:2016
-
负责人:Parisa Hosseinzadeh
-
依托单位:
海外基金